Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel

Michael Mitas, Kaidi Mikhitarian, Kenneth C Walters, Paul L. Baron, Bruce M. Elliott, Thomas E. Brothers, Jay G. Robison, John S. Metcalf, Yuko Y. Palesch, Zhen Zhang, William E. Gillanders, David J. Cole

Research output: Contribution to journalArticle

177 Citations (Scopus)

Abstract

Real-time RT-PCR is a relatively new technology that uses an online fluorescence detection system to determine gene expression levels. It has the potential to significantly improve detection of breast cancer metastasis by virtue of its exquisite sensitivity, high throughput capacity and quantitative readout system. To assess the utility of this technology in breast cancer staging, we determined the relative expression levels of 12 cancer-associated genes (mam, PIP, mamB, CEA, CK19, VEGF, erbB2, muc1, c-myc, p97, vim and Ki67) in 51 negative-control normal lymph nodes and in 17 histopathology-positive ALNs. We then performed a receiver operating characteristic (ROC) curve analysis to determine the sensitivity and specificity levels of each gene. Areas under the ROC curve indicated that the most accurate diagnostic markers were mam (99.6%), PIP (93.3%), CK19 (91.0%), mamB (87.9%), muc1 (81.5%) and CEA (79.4.0%). mam was overexpressed in 16 of 17 lymph nodes known to contain metastatic breast cancer at levels ranging from 22- to 2.8 × 105-fold above normal mean expression, whereas PIP was overexpressed from 30- to 2.2 × 106-fold above normal in 13 lymph nodes. Real-time RT-PCR analysis of pathology-negative LN from breast cancer patients revealed evidence of overexpression of PIP (6 nodes), mam (3 nodes) and CEA (1 node) in 8 of 21 nodes (38%). Our results provide evidence that mare, PIP, CK19, mamB, muc1 and CEA can be applied as a panel for detection of metastatic and occult micrometastatic disease.

Original languageEnglish (US)
Pages (from-to)162-171
Number of pages10
JournalInternational Journal of Cancer
Volume93
Issue number2
DOIs
StatePublished - Jul 15 2001

Fingerprint

Neoplasm Micrometastasis
Real-Time Polymerase Chain Reaction
Breast Neoplasms
Lymph Nodes
ROC Curve
Technology
Neoplasm Staging
Neoplasm Genes
Vascular Endothelial Growth Factor A
Fluorescence
Pathology
Neoplasm Metastasis
Gene Expression
Sensitivity and Specificity
Genes

Keywords

  • Axillary lymph node
  • Breast cancer genes
  • Diagnostic
  • ROC analysis
  • SYBR Green I chemistry
  • Sentinel lymph node

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. / Mitas, Michael; Mikhitarian, Kaidi; Walters, Kenneth C; Baron, Paul L.; Elliott, Bruce M.; Brothers, Thomas E.; Robison, Jay G.; Metcalf, John S.; Palesch, Yuko Y.; Zhang, Zhen; Gillanders, William E.; Cole, David J.

In: International Journal of Cancer, Vol. 93, No. 2, 15.07.2001, p. 162-171.

Research output: Contribution to journalArticle

Mitas, M, Mikhitarian, K, Walters, KC, Baron, PL, Elliott, BM, Brothers, TE, Robison, JG, Metcalf, JS, Palesch, YY, Zhang, Z, Gillanders, WE & Cole, DJ 2001, 'Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel', International Journal of Cancer, vol. 93, no. 2, pp. 162-171. https://doi.org/10.1002/ijc.1312
Mitas, Michael ; Mikhitarian, Kaidi ; Walters, Kenneth C ; Baron, Paul L. ; Elliott, Bruce M. ; Brothers, Thomas E. ; Robison, Jay G. ; Metcalf, John S. ; Palesch, Yuko Y. ; Zhang, Zhen ; Gillanders, William E. ; Cole, David J. / Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. In: International Journal of Cancer. 2001 ; Vol. 93, No. 2. pp. 162-171.
@article{f682be6e82704fb29e49653dd548753f,
title = "Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel",
abstract = "Real-time RT-PCR is a relatively new technology that uses an online fluorescence detection system to determine gene expression levels. It has the potential to significantly improve detection of breast cancer metastasis by virtue of its exquisite sensitivity, high throughput capacity and quantitative readout system. To assess the utility of this technology in breast cancer staging, we determined the relative expression levels of 12 cancer-associated genes (mam, PIP, mamB, CEA, CK19, VEGF, erbB2, muc1, c-myc, p97, vim and Ki67) in 51 negative-control normal lymph nodes and in 17 histopathology-positive ALNs. We then performed a receiver operating characteristic (ROC) curve analysis to determine the sensitivity and specificity levels of each gene. Areas under the ROC curve indicated that the most accurate diagnostic markers were mam (99.6{\%}), PIP (93.3{\%}), CK19 (91.0{\%}), mamB (87.9{\%}), muc1 (81.5{\%}) and CEA (79.4.0{\%}). mam was overexpressed in 16 of 17 lymph nodes known to contain metastatic breast cancer at levels ranging from 22- to 2.8 × 105-fold above normal mean expression, whereas PIP was overexpressed from 30- to 2.2 × 106-fold above normal in 13 lymph nodes. Real-time RT-PCR analysis of pathology-negative LN from breast cancer patients revealed evidence of overexpression of PIP (6 nodes), mam (3 nodes) and CEA (1 node) in 8 of 21 nodes (38{\%}). Our results provide evidence that mare, PIP, CK19, mamB, muc1 and CEA can be applied as a panel for detection of metastatic and occult micrometastatic disease.",
keywords = "Axillary lymph node, Breast cancer genes, Diagnostic, ROC analysis, SYBR Green I chemistry, Sentinel lymph node",
author = "Michael Mitas and Kaidi Mikhitarian and Walters, {Kenneth C} and Baron, {Paul L.} and Elliott, {Bruce M.} and Brothers, {Thomas E.} and Robison, {Jay G.} and Metcalf, {John S.} and Palesch, {Yuko Y.} and Zhen Zhang and Gillanders, {William E.} and Cole, {David J.}",
year = "2001",
month = "7",
day = "15",
doi = "10.1002/ijc.1312",
language = "English (US)",
volume = "93",
pages = "162--171",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel

AU - Mitas, Michael

AU - Mikhitarian, Kaidi

AU - Walters, Kenneth C

AU - Baron, Paul L.

AU - Elliott, Bruce M.

AU - Brothers, Thomas E.

AU - Robison, Jay G.

AU - Metcalf, John S.

AU - Palesch, Yuko Y.

AU - Zhang, Zhen

AU - Gillanders, William E.

AU - Cole, David J.

PY - 2001/7/15

Y1 - 2001/7/15

N2 - Real-time RT-PCR is a relatively new technology that uses an online fluorescence detection system to determine gene expression levels. It has the potential to significantly improve detection of breast cancer metastasis by virtue of its exquisite sensitivity, high throughput capacity and quantitative readout system. To assess the utility of this technology in breast cancer staging, we determined the relative expression levels of 12 cancer-associated genes (mam, PIP, mamB, CEA, CK19, VEGF, erbB2, muc1, c-myc, p97, vim and Ki67) in 51 negative-control normal lymph nodes and in 17 histopathology-positive ALNs. We then performed a receiver operating characteristic (ROC) curve analysis to determine the sensitivity and specificity levels of each gene. Areas under the ROC curve indicated that the most accurate diagnostic markers were mam (99.6%), PIP (93.3%), CK19 (91.0%), mamB (87.9%), muc1 (81.5%) and CEA (79.4.0%). mam was overexpressed in 16 of 17 lymph nodes known to contain metastatic breast cancer at levels ranging from 22- to 2.8 × 105-fold above normal mean expression, whereas PIP was overexpressed from 30- to 2.2 × 106-fold above normal in 13 lymph nodes. Real-time RT-PCR analysis of pathology-negative LN from breast cancer patients revealed evidence of overexpression of PIP (6 nodes), mam (3 nodes) and CEA (1 node) in 8 of 21 nodes (38%). Our results provide evidence that mare, PIP, CK19, mamB, muc1 and CEA can be applied as a panel for detection of metastatic and occult micrometastatic disease.

AB - Real-time RT-PCR is a relatively new technology that uses an online fluorescence detection system to determine gene expression levels. It has the potential to significantly improve detection of breast cancer metastasis by virtue of its exquisite sensitivity, high throughput capacity and quantitative readout system. To assess the utility of this technology in breast cancer staging, we determined the relative expression levels of 12 cancer-associated genes (mam, PIP, mamB, CEA, CK19, VEGF, erbB2, muc1, c-myc, p97, vim and Ki67) in 51 negative-control normal lymph nodes and in 17 histopathology-positive ALNs. We then performed a receiver operating characteristic (ROC) curve analysis to determine the sensitivity and specificity levels of each gene. Areas under the ROC curve indicated that the most accurate diagnostic markers were mam (99.6%), PIP (93.3%), CK19 (91.0%), mamB (87.9%), muc1 (81.5%) and CEA (79.4.0%). mam was overexpressed in 16 of 17 lymph nodes known to contain metastatic breast cancer at levels ranging from 22- to 2.8 × 105-fold above normal mean expression, whereas PIP was overexpressed from 30- to 2.2 × 106-fold above normal in 13 lymph nodes. Real-time RT-PCR analysis of pathology-negative LN from breast cancer patients revealed evidence of overexpression of PIP (6 nodes), mam (3 nodes) and CEA (1 node) in 8 of 21 nodes (38%). Our results provide evidence that mare, PIP, CK19, mamB, muc1 and CEA can be applied as a panel for detection of metastatic and occult micrometastatic disease.

KW - Axillary lymph node

KW - Breast cancer genes

KW - Diagnostic

KW - ROC analysis

KW - SYBR Green I chemistry

KW - Sentinel lymph node

UR - http://www.scopus.com/inward/record.url?scp=0035879753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035879753&partnerID=8YFLogxK

U2 - 10.1002/ijc.1312

DO - 10.1002/ijc.1312

M3 - Article

C2 - 11410861

AN - SCOPUS:0035879753

VL - 93

SP - 162

EP - 171

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -